Search filters

List of works by Eric Winer

18F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials

scientific article published on 23 December 2016

1st International consensus guidelines for advanced breast cancer (ABC 1).

scientific article published on 16 March 2012

2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology

scientific article

3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).

scientific article published on 19 February 2017

3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).

scientific article

3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3).

scientific article

4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†

scientific article published on 01 August 2018

5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)†

scientific article published on 23 September 2020

A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer

scientific article published in 2022

A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer

scientific article

A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer ⬇️

scientific article published on July 19, 2013

A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB)

scientific article published on 05 February 2019

A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer

scientific article published on 30 January 2020

A Phase II Study of Sagopilone (ZK 219477; ZK-EPO) in Patients With Breast Cancer and Brain Metastases ⬇️

scientific article published on June 22, 2011

A Phase Ib Study of Alpelisib (BYL719), a PI3Kα-Specific Inhibitor, with Letrozole in ER+/HER2- Metastatic Breast Cancer

scientific article published on 28 April 2016

A Randomized Placebo-Controlled Phase 2 Trial Evaluating Exemestane With or Without Enzalutamide in Patients With Hormone Receptor-positive Breast Cancer

scientific article published on 28 September 2020

A comparative study of exemestane versus anastrozole in patients with postmenopausal breast cancer with visceral metastases

scientific article

A dickens tale of the treatment of advanced breast cancer: the past, the present, and the future

scientific article published on January 2012

A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.

scientific article

A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases

scientific article

A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma

scientific article published on 01 September 2019

A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab ⬇️

scientific article published on March 15, 2012

A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer ⬇️

scientific article published on May 5, 2013

A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastases

scientific article published on 20 September 2019

A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer ⬇️

scientific article published on 04 April 2013

A phase II study of preoperative capecitabine in women with operable hormone receptor positive breast cancer.

scientific article published on 27 January 2014

A phase II study of trastuzumab emtansine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who were previously treated with trastuzumab, lapatinib, an anthracycline, a taxane, and capecitabine

scientific article

A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer

A planned, prospective comparison of short-term quality of life outcomes among older patients with breast cancer treated with standard chemotherapy in a randomized clinical trial vs. an observational study: CALGB #49907 and #369901.

scientific article published on 20 June 2013

A randomized, double-blinded, controlled study of tucatinib (ONT-380) vs. placebo in combination with capecitabine (C) and trastuzumab (Tz) in patients with pretreated HER2+ unresectable locally advanced or metastatic breast carcinoma (mBC) (HER2CLIM

Abstract CT026: A phase II trial of neratinib (NER) or NER plus fulvestrant (FUL) (N+F) in HER2 mutant, non-amplified (HER2mut) metastatic breast cancer (MBC): Part II of MutHER

scientific article published in 2021

Abstract OT1-01-06: A phase III randomized trial of atezolizumab in combination with nab-paclitaxel as first line therapy for patients with metastatic triple-negative breast cancer (mTNBC)

Abstract P5-12-02: <i>PTEN</i> alterations and tumor mutational burden (TMB) as potential predictors of resistance or response to immune checkpoint inhibitors (ICI) in metastatic triple-negative breast cancer (mTNBC)

scientific article published on 11 May 2019

Abstract P5-19-09: Preliminary results from a phase 2 single-arm study of enzalutamide, an androgen receptor (AR) inhibitor, in advanced AR+ triple-negative breast cancer (TNBC)

Abstract PS4-25: Comprehensive genomic analysis reveals molecular correlates of response to immune checkpoint inhibitors (ICI) in metastatic triple-negative breast cancer (mTNBC)

scientific article published on 15 February 2021

Abstract S2-02: The FERGI phase II study of the PI3K inhibitor pictilisib (GDC-0941) plus fulvestrant vs fulvestrant plus placebo in patients with ER+, aromatase inhibitor (AI)-resistant advanced or metastatic breast cancer – Part I results

scientific article published in 2015

Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527

scientific article published on 19 December 2016

Acquired FGFR and FGF alterations confer resistance to estrogen receptor (ER) targeted therapy in ER+ metastatic breast cancer

scientific article published on 28 July 2020

Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor-directed therapies

scientific article published on 10 December 2018

Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104

scientific article

Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer

scientific article published on 7 January 2008

Adherence to therapy with oral antineoplastic agents

scientific article (publication date: May 2002)

Adjuvant Chemotherapy for ER+ Breast Cancer: A Sea Change is Underway

scientific article published on 01 May 2018

Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update

scientific article published on 19 November 2018

Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression

scientific article published on 16 February 2016

Adjuvant chemotherapy for older patients with breast cancer:  When is the pain worth the gain?

scientific article published on 15 October 2019

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer

scientific article

Adjuvant chemotherapy in older women with early-stage breast cancer

scientific article

Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update

scientific article

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer

scientific article

Adjuvant ovarian suppression in premenopausal breast cancer

scientific article

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer ⬇️

scientific article

Adjuvant therapy for postmenopausal women with endocrine-sensitive breast cancer

scientific article published on 19 January 2010

Advances in adjuvant endocrine therapy for postmenopausal women

scientific article published on February 2008

Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI

scientific article published on 18 May 2007

Aggressive Subsets of Metastatic Triple Negative Breast Cancer

scientific article published on 31 July 2019

Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations

scientific article published in February 2018

American Society of Clinical Oncology Policy Statement: Opportunities in the Patient Protection and Affordable Care Act to Reduce Cancer Care Disparities ⬇️

scientific article published on October 1, 2011

American Society of Clinical Oncology Technology Assessment Working Group Update: Use of Aromatase Inhibitors in the Adjuvant Setting ⬇️

scientific article published on 05 May 2003

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer

scientific article

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer

scientific article

American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition

scientific article

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

scientific article

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.

scientific article

Amifostine and chemoradiation therapy: ASCO responds ⬇️

scientific article published on October 1, 2003

An FDA Analysis of Survival Outcomes Comparing an Adjuvant Paclitaxel and Trastuzumab Trial to an External Control from Historical Clinical Trials

scientific article published on 28 August 2020

Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses' Health Studies

scientific article published on 15 November 2018

Applying a conceptual model for examining health-related quality of life in long-term breast cancer survivors: CALGB study 79804.

scientific article

Aromatase Inhibition in Obese Women: How Much Is Enough? ⬇️

scientific article published on July 16, 2012

Aromatase inhibitors and arthralgias: a new frontier in symptom management for breast cancer survivors

scientific article published on 01 September 2007

Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions

scientific article

Assessment of a dietary questionnaire in cancer patients receiving cytotoxic chemotherapy

scientific article

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

scientific article published on 01 April 2007

Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer.

scientific article published on 3 January 2018

Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast cancer survivors: CALGB/Alliance 369901.

scientific article

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial

scientific article published on 27 November 2019

Attitudes of patients with metastatic breast cancer toward research biopsies

scientific article

Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2

scientific article published on 01 March 1999

Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses

scientific article published on July 2003

Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial

scientific article published in September 2010

Author's reply: Use of discard pleural fluid in molecular research

scientific article published on January 2012

Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study

scientific article published on 24 April 2020

Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative).

scientific article published on 12 January 2017

Barriers to Clinical Trial Accrual: Perspectives of Community-Based Providers

scientific article published on 07 May 2020

Blood vessel morphologic changes depicted with MR angiography during treatment of brain metastases: a feasibility study

scientific article

Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance).

scientific article

Body image in recently diagnosed young women with early breast cancer ⬇️

scientific article published on November 7, 2012

Brain metastases: the HER2 paradigm

scientific article published on March 2007

Breast Cancer

Breast Cancer Survivors' Perceptions of Survivorship Care Options ⬇️

scientific article published on December 12, 2011

Breast Cancer Treatment: A Review

scientific article published on 01 January 2019

Breast Cancer: Noninvasive and Special Situations

article

Breast cancer

scientific article published on 01 May 2005

Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians

scientific article

Breast cancer presentation and diagnostic delays in young women

scientific article

Breast cancer-specific survival by age: Worse outcomes for the oldest patients

scientific article published on 02 March 2018

Breast cancer. Clinical practice guidelines in oncology

scientific article

Breast cancer: T-DM1 - an important agent in the history of breast cancer management

scientific article published on 08 August 2017

Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence score

scientific article published on 20 September 2011

Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival

scientific article published on 26 June 2008

CDK4/6 inhibition in breast cancer: current practice and future directions

scientific article published on 17 July 2018

CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity

scientific article published on 09 November 2020

CDK4/6 inhibition triggers anti-tumour immunity.

scientific article published on 16 August 2017

CMF revisited in the 21st century ⬇️

scientific article published on June 29, 2011

CNS metastases in breast cancer

scientific article published in September 2004

Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study

scientific article published on 06 October 2016

Can Axillary Node Dissection Be Omitted in a Subset of Patients with Low Local and Regional Failure Rates? ⬇️

scientific article published on October 21, 2011

Can we really use retrospective subset analyses and surveillance, epidemiology, and end results data to drive clinical practice?

scientific article published on 30 July 2012

Cancer and leukemia group B breast committee: decades of progress and plans for the future

scientific article

Cancer-related communication between female patients and male partners scale: A pilot study

scientific article published in September 2006

Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer.

scientific article published on 5 November 2015

Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial

scientific article

Cardiac toxicity from systemic cancer therapy: a comprehensive review.

scientific article published on September 2010

Care in the months before death and hospice enrollment among older women with advanced breast cancer

scientific article

Case records of the Massachusetts General Hospital. Case 32-2007. A 62-year-old woman with a second breast cancer

scientific article published in October 2007

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma

scientific article

Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy

scientific article published in May 2001

Characterization of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.

scientific article published on 28 October 2017

Chemotherapy Agents in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Time to Step Out of the Limelight ⬇️

scientific article published on December 13, 2010

Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).

scientific article published on 16 May 2015

Choosing the best trastuzumab-based adjuvant chemotherapy regimen: should we abandon anthracyclines?

scientific article

Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500

scientific article

Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

scientific article

Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer

scientific article

Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

scientific article published on 17 December 2007

Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

scientific article published on 22 December 2008

Clinical differences among the aromatase inhibitors.

scientific article

Clinical efficacy and molecular response correlates of the WEE1 inhibitor adavosertib combined with cisplatin in patients with metastatic triple-negative breast cancer (mTNBC)

scientific article published on 30 November 2020

Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era ⬇️

scientific article published on January 23, 2013

Clinical significance of circulating tumor cells in hormone receptor-positive metastatic breast cancer patients who received letrozole with or without bevacizumab

scientific article published on 25 June 2020

Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer Network ⬇️

scientific article published on April 27, 2012

Clinicopathological features among patients with advanced human epidermal growth factor-2-positive breast cancer with prolonged clinical benefit to first-line trastuzumab-based therapy: a retrospective cohort study

scientific article

Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907.

scientific article published on 17 May 2013

Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomics

scientific article

Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study

scientific article

Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases

scientific article published on 06 June 2016

Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance)

scientific article

Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance).

scientific article

Complementary and alternative medicine use among women with breast cancer

scientific article published on 01 September 2002

Consultation with a medical oncologist before surgery and type of surgery among elderly women with early-stage breast cancer

scientific article published on 01 December 2003

Correction: 18F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials

scientific article published on 01 February 2019

Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259].

scientific article published on 18 January 2017

Cost-effectiveness of switching to exemestane after 2 to 3 years of therapy with tamoxifen in postmenopausal women with early-stage breast cancer

scientific article published on September 2007

De-Escalating Breast Cancer Surgery for Low-Risk Ductal Carcinoma in Situ-Reply

scientific article published on 07 May 2020

De-escalating Breast Cancer Surgery-Where Is the Tipping Point?

scientific article published on 12 December 2019

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

scientific article published on 01 August 2017

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

scientific article published on 01 October 2018

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

scientific article published on 01 July 2019

Defining success in neoadjuvant breast cancer trials

scientific article published on 14 February 2014

Do cancer patients fully understand clinical trial participation? A pilot study to assess informed consent and patient expectations

article by Ricardo J Wray et al published 2007 in Journal of Cancer Education

Do patients participating in clinical trials want to know study results?

scientific article published on 01 March 2003

Docetaxel administered on a weekly basis for metastatic breast cancer

scientific article published on 01 March 2000

Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?

scientific article published on November 2007

Does Neoadjuvant Bevacizumab Increase Surgical Complications in Breast Surgery? ⬇️

scientific article published on September 30, 2010

Dose density in breast cancer: a simple message?

scientific article

Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction

scientific article published on 9 November 2009

Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea

scientific article published on 17 May 2010

Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide follow

scientific article published on 30 January 2008

Drug resistance in HER2-positive breast cancer brain metastases: blame the barrier or the brain?

scientific article published on 6 February 2018

Duration and toxicity of adjuvant trastuzumab in older patients with early-stage breast cancer: a population-based study

scientific article published on 10 February 2014

E6. Can an international consensus meeting change the future of advanced breast cancer patients? Highlights from ABC1 Consensus Meeting

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).

scientific article

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†

scientific article

Economic outcomes of breast cancer survivorship: CALGB study 79804.

scientific article published in May 2005

Effect of Age on Breast Cancer Outcomes in Women With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From a Herceptin Adjuvant Trial ⬇️

scientific article published on June 10, 2013

Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical Trial

scientific article published on 03 September 2020

Effect of Exercise or Metformin on Biomarkers of Inflammation in Breast and Colorectal Cancer: A Randomized Trial

scientific article published on 28 August 2020

Effect of Massachusetts health insurance reform on mammography use and breast cancer stage at diagnosis ⬇️

scientific article published on July 25, 2012

Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer

scientific article published on 22 May 2008

Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials

scientific article

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer

scientific article

Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy

scientific article

Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference

scientific article published on February 2008

Endocrine therapy with or without inhibition of epidermal growth factor receptor and human epidermal growth factor receptor 2: a randomized, double-blind, placebo-controlled phase III trial of fulvestrant with or without lapatinib for postmenopausal

scientific article

Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer

scientific article published on 26 January 2018

Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019

scientific article published on 01 October 2019

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

scientific article

Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials

scientific article published on 02 July 2019

Extended therapy with letrozole and ovarian suppression in premenopausal patients with breast cancer after tamoxifen.

scientific article published on 2 June 2014

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

scientific article

Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer

scientific article

Factors Associated with Early Mortality Among Patients with De Novo Metastatic Breast Cancer: A Population-Based Study

scientific article published on 27 February 2017

Factors contributing to patient satisfaction with breast reconstruction using silicone gel implants

scientific article published on 01 June 1996

Factors related to underuse of surveillance mammography among breast cancer survivors

scientific article published in January 2006

Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.

scientific article published in June 2004

Fertility after breast cancer: questions abound

scientific article published on 11 April 2005

Fertility and menopausal outcomes in young breast cancer survivors

scientific article published on February 2008

Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944)

scientific article

Follow-up care of breast cancer survivors

scientific article published on 01 December 2003

Follow-up care of patients with breast cancer

scientific article published on 13 August 2007

Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901.

scientific article

Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance).

scientific article published on 31 March 2017

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer

scientific article published on 14 March 2016

Further progress in HER2-directed therapy ⬇️

scientific article published on January 1, 2012

GPHMM: an integrated hidden Markov model for identification of copy number alteration and loss of heterozygosity in complex tumor samples using whole genome SNP arrays

scientific article

Genetic testing for susceptibility to breast cancer: findings from women's focus groups

scientific article

Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

scientific article published on 26 September 2015

Genomic Profiling in Node-Positive ER-Positive Early Breast Cancer: Can Tumor Biology Guide Locoregional Therapy?

scientific article

Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial.

scientific article

Genomic characterization of de novo metastatic breast cancer

scientific article published on 08 December 2020

Genomic features of rapid versus late relapse in triple negative breast cancer

scientific article published on 18 May 2021

HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis

scientific article published in March 2004

HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

article

HER2 or not HER2: that is the question

scientific article published on 28 February 2005

HER2 testing in breast cancer: NCCN Task Force report and recommendations.

scientific article published on July 2006

Heterogeneity of breast cancer and implications of adjuvant chemotherapy

scientific article

High performance teamwork training and systems redesign in outpatient oncology ⬇️

scientific article published on January 24, 2013

Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.

scientific article

Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer

scientific article published on 07 May 2018

Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes?

scientific article published on 28 September 2012

I-SPY 2--Toward More Rapid Progress in Breast Cancer Treatment

scientific article published in July 2016

Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study

article

Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials

scientific article published on 15 November 2019

Identifying gaps in the locoregional management of early breast cancer: highlights from the Kyoto Consensus Conference.

scientific article

Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to PreoperativeTrastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer

scientific article

Impact of a Pre-Operative Exercise Intervention on Breast Cancer Proliferation and Gene Expression: Results from the Pre-Operative Health and Body (PreHAB) Study

scientific article published on 24 April 2019

Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors

scientific article

Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors

scientific article published on 13 May 2009

Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance)

scientific article

Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance).

scientific article

Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40

scientific article

In Reply:

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

Influence of birthplace on breast cancer diagnosis and treatment for Hispanic women

scientific article published in December 2009

Informed consent for BRCA1 and BRCA2 testing.

scientific article

Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

scientific article published on 23 July 2018

Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy

scientific article published on 30 November 2012

Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806

article

International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer

scientific article published on 17 April 2013

International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?

scientific article

International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy

scientific article published on 05 August 2009

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial

scientific article published on 29 May 2020

Introducing Breast Cancer Research's updates on clinical trials

scientific article

Invasive breast cancer

scientific article

Is axillary lymph node dissection indicated for early-stage breast cancer? A decision analysis

scientific article published on 01 May 1999

Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy

scientific article

Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance).

scientific article published on 3 January 2017

Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance).

scientific article published on 15 June 2017

Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma

scientific article published in January 2002

Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer

scientific article

Local therapy and survival in breast cancer

scientific article published on June 2007

Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial)

scientific article published on 19 April 2019

Long-Term Risk Perceptions of Women With Ductal Carcinoma In Situ ⬇️

scientific article published on April 8, 2013

Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer

scientific article published on 26 August 2013

Long-term complications of adjuvant chemotherapy for early stage breast cancer

scientific article

Long-term follow-up after preoperative trastuzumab and chemotherapy for HER2-overexpressing breast cancer.

scientific article published on 15 August 2014

Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer

scientific article published on 01 October 2007

Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer

scientific article published in September 2004

Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343

scientific article published on 20 May 2013

Lumping versus splitting: the splitters take this round

scientific article published on 01 September 2002

Lymphedema, musculoskeletal events and arm function in older patients receiving adjuvant chemotherapy for breast cancer (Alliance A171302).

scientific article

Lymphopenia associated with adjuvant anthracycline/ taxane regimens

scientific article published in August 2008

Male breast cancer networking and telephone support group: a model for supporting a unique population

scientific article published on 02 April 2014

Menopausal-type symptoms in young breast cancer survivors

scientific article published on 13 September 2006

Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade

scientific article published on 05 December 2018

Model Program to Improve Care for a Unique Cancer Population: Young Women With Breast Cancer ⬇️

scientific article published on May 22, 2012

Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib.

scientific article

Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women

scientific article published on 29 May 2015

Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer

scientific article published on 21 September 2021

Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342

scientific article published on January 2006

Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer

scientific article published in February 2009

Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer

scientific article (publication date: 15 March 2003)

NCCN Task Force Report: Adjuvant Therapy for Breast Cancer.

scientific article

NCCN Task Force Report: breast cancer in the older woman

scientific article published on January 2008

NI-23BRAIN BREAST METASTASES RESPOND TO ANTI-ANGIOGENIC THERAPY BY MODES OF VASCULAR NORMALIZATION

scientific article published in November 2014

Neoadjuvant bevacizumab: surgical complications of mastectomy with and without reconstruction

scientific article published on 13 September 2013

Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer.

scientific article

New combinations with Herceptin in metastatic breast cancer

scientific article

New cytotoxic agents and schedules for advanced breast cancer

scientific article

New targets for therapy in breast cancer: small molecule tyrosine kinase inhibitors

scientific article

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer

scientific article published in February 2003

Offering participants results of a clinical trial: sharing results of a negative study

scientific article published on 01 March 2005

Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial

scientific article published on 14 March 2019

On mammography--more agreement than disagreement

scientific article published on 25 November 2009

Oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participants

scientific article published on April 2004

Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center

scientific article published on 16 September 2020

Optimal use of aromatase inhibitors: to lead or to follow?

scientific article published on 11 June 2007

Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis

scientific article published on 5 July 2005

Optimizing endocrine therapy for estrogen receptor-positive breast cancer: treating the right patients for the right length of time

scientific article published on 10 March 2008

Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study

scientific article

Outcomes following local therapy for early-stage breast cancer in non-trial populations

scientific article (publication date: February 2011)

Ovarian suppression for breast cancer: an effective treatment in search of a home

scientific article published on 8 August 2005

Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors

scientific article published on March 2016

Overestimation of Hereditary Breast Cancer Risk ⬇️

scientific article published on 01 September 1998

PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance).

scientific article

PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer

scientific article published on 20 February 2013

PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers

scientific article published on 26 October 2015

PIK3CA and MAP3K1 alterations imply luminal A status and are associated with clinical benefit from pan-PI3K inhibitor buparlisib and letrozole in ER+ metastatic breast cancer

scientific article published on 23 September 2019

PIK3CA(H1047R)- and Her2-initiated mammary tumors escape PI3K dependency by compensatory activation of MEK-ERK signaling

scientific article published on 07 December 2015

Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840 ⬇️

scientific article published on June 21, 2011

Passion for Immune checkpoint blockade in triple negative breast cancer? Comment on the IMpassion130 study

article

Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer ⬇️

scientific article published on November 13, 2011

Patient Motivation, Satisfaction, and Coping in Genetic Counseling and Testing for BRCA1 and BRCA2.

scientific article

Patient utilities for advanced cancer: effect of current health on values

scientific article published on 01 February 2005

Patient-reported outcomes from the phase III IMpassion130 trial of atezolizumab plus nab-paclitaxel in metastatic triple-negative breast cancer

scientific article published on 20 February 2020

Patterns of Utilization of Imaging Studies and Serum Tumor Markers Among Patients With De Novo Metastatic Breast Cancer

scientific article published in March 2017

Patterns of bone density evaluation in a community population treated with aromatase inhibitors ⬇️

scientific article published on July 12, 2012

Patterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy

scientific article published on 23 April 2014

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

scientific article published on 01 March 2019

Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study

scientific article published on 01 March 2019

Perceptions and management approaches of physicians who care for women with ductal carcinoma in situ

scientific article published on 01 June 2008

Perceptions of patients with early stage breast cancer toward research biopsies

scientific article published on 15 December 2020

Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey

scientific article published on September 2013

Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907) ⬇️

scientific article published on July 5, 2012

Personalization of loco-regional care for primary breast cancer patients (part 1).

scientific article published in January 2015

Personalization of loco-regional care for primary breast cancer patients (part 2).

scientific article published on January 2015

Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance)

scientific article published on 04 December 2019

Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice

scientific article

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 ⬇️

scientific article published on August 4, 2013

Pertuzumab: Optimizing HER2 Blockade ⬇️

scientific article published on August 13, 2013

Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis

scientific article

Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer

scientific article published on 02 November 2020

Phase 2 study of pembrolizumab (pembro) monotherapy for previously treated metastatic triple-negative breast cancer (mTNBC): KEYNOTE-086 cohort A

Phase 2 study of pembrolizumab as first-line therapy for PD-L1–positive metastatic triple-negative breast cancer (mTNBC): Preliminary data from KEYNOTE-086 cohort B

Phase I dose escalation study of the PI3kinase pathway inhibitor BKM120 and the oral poly (ADP ribose) polymerase (PARP) inhibitor olaparib for the treatment of high-grade serous ovarian and breast cancer.

scientific article published on 19 December 2016

Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases

scientific article published on 24 May 2020

Phase I study of Doxil and vinorelbine in metastatic breast cancer

scientific article published on 01 September 1999

Phase I study of nonpegylated liposomal doxorubicin plus trastuzumab in patients with HER2-positive breast cancer.

scientific article published in May 2009

Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHL.

scientific article

Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors

article

Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast cancer.

scientific article

Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy.

scientific article

Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance)

scientific article published on 03 March 2020

Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomogr

scientific article

Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients

scientific article published on 27 October 2016

Phase II evaluation of thalidomide in patients with metastatic breast cancer

scientific article published on 01 July 2000

Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions

scientific article published on 08 March 2007

Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancer.

scientific article

Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer

scientific article

Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation

scientific article published on 05 July 2019

Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases

scientific article published on 30 November 2020

Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer

scientific article published in April 2008

Phase II, randomized, double-blind study of two dose levels of arzoxifene in patients with locally advanced or metastatic breast cancer

scientific article

Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance)

scientific article published on 02 May 2016

Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.

scientific article

Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ

scientific article

Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancer

scientific article published on August 2010

Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial.

scientific article

Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer.

scientific article published on November 2006

Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors

scientific article published on 29 September 2015

Poly(ADP-Ribose) polymerase inhibition: "targeted" therapy for triple-negative breast cancer

scientific article

Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance).

scientific article

Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022

scientific article published on 22 August 2019

Pre-counseling education materials for BRCA testing: does tailoring make a difference?

scientific article published on 01 January 2002

Predicting response and survival in chemotherapy-treated triple-negative breast cancer.

scientific article

Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer

scientific article

Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference.

scientific article

Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease

scientific article published on February 2008

Preoperative therapy in invasive breast cancer: reviewing the state of the science and exploring new research directions

scientific article published on February 2008

Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study.

scientific article

Prevalence and mutational determinants of high tumor mutation burden in breast cancer

scientific article published on 09 January 2020

Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: conference summary statement

scientific article published in February 2006

Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer

scientific article published on 01 February 2005

Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer

scientific article published on 06 December 2019

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

scientific article

Prospective clinical experience with research biopsies in breast cancer patients

scientific article published on 11 October 2013

Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer

scientific article published on 21 October 2005

Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast

scientific article published on 01 January 2009

Protocol for the examination of specimens from patients with invasive carcinoma of the breast

scientific article published on 01 October 2009

Psychosexual Functioning and Body Image Following a Diagnosis of Ductal Carcinoma In Situ ⬇️

scientific article published on July 19, 2012

Quality of Life in Long-Term Survivors of Metastatic Breast Cancer ⬇️

scientific article published on April 1, 2012

Quality of Life of Older Patients With Early-Stage Breast Cancer Receiving Adjuvant Chemotherapy: A Companion Study to Cancer and Leukemia Group B 49907 ⬇️

scientific article published on February 7, 2011

Quality of Non–Breast Cancer Health Maintenance Among Elderly Breast Cancer Survivors ⬇️

scientific article published on April 15, 2003

Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.

scientific article published in October 2005

Quality of life and symptoms in male breast cancer survivors

scientific article published on 11 January 2013

Quality of life issues among women undergoing high-dose chemotherapy for breast cancer

scientific article published on 01 January 2001

Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors

scientific article published on 11 May 2015

Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B.

scientific article published on June 2008

Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?

scientific article published in July 2009

Racial differences in outcomes for patients with metastatic breast cancer by disease subtype

scientific article

Racial/Ethnic differences in receipt of timely adjuvant therapy for older women with breast cancer: are delays influenced by the hospitals where patients obtain surgical care?

scientific article published on 13 May 2013

Randomized Phase II Trial of Exercise, Metformin, or Both on Metabolic Biomarkers in Colorectal and Breast Cancer Survivors

scientific article published on 20 November 2019

Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NC

scientific article published on 8 June 2015

Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer an

article

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

article

Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial

scientific article published on 24 July 2019

Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases ⬇️

scientific article published on June 26, 2011

Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design

scientific article published on 21 September 2017

Randomized trial of a physical activity intervention in women with metastatic breast cancer

scientific article

Rebeccamycin analog for refractory breast cancer: a randomized phase II trial of dosing schedules

scientific article

Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update

scientific article published on 25 June 2018

Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American Society of Clinical Oncology clinical practice guideline.

scientific article

Reducing disparities in breast cancer care: a daunting but essential responsibility

scientific article published on 25 November 2008

Refining therapy for human epidermal growth factor receptor 2-positive breast cancer: T stands for trastuzumab, tumor size, and treatment strategy

scientific article published on 2 November 2009

Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial

scientific article

Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al.

scientific article

Reply to A.K. Goel et al

scientific article published on 13 September 2019

Reply to P.G. Tsoutsou et al, o. Kaidar-Person et al, and A. Courdi et al

scientific article published on 04 November 2013

Reply to S. Mahesh

scientific article

Reply to V. Amoroso et al

scientific article published on 15 December 2014

Response

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer

scientific article published on 6 January 2016

Response of Brain Metastases From PIK3CA-Mutant Breast Cancer to Alpelisib

scientific article published on 27 May 2020

Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer

scientific article published on 04 November 2020

Response: Re: International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy

Responses to subsequent anti-HER2 therapy after treatment with trastuzumab-DM1 in women with HER2-positive metastatic breast cancer ⬇️

scientific article published on April 29, 2011

Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer

scientific article published on 20 February 2020

Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial

scientific article published on 30 May 2019

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

scientific article published on 7 October 2016

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).

scientific article published on 19 November 2016

Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patients ⬇️

scientific article published on September 1, 2011

Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study

scientific article published on 12 February 2008

Road Map to Safe and Well-Designed De-escalation Trials of Systemic Adjuvant Therapy for Solid Tumors

scientific article published on 14 October 2020

Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients.

scientific article

STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer

scientific article published on 31 May 2022

SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer

scientific article

Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642.

scientific article published in May 1999

Sarcoidosis mimicking metastatic breast cancer

scientific article

Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.

scientific article published on 6 November 2017

Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: summary consensus statement.

scientific article

Self-reported practices and attitudes of US oncologists regarding off-protocol therapy

scientific article published on 24 November 2008

Sensitive detection of minimal residual disease in patients treated for early-stage breast cancer

scientific article published on 13 March 2020

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk

scientific article published on 01 July 1998

Serial analysis of circulating tumor cells in metastatic breast cancer receiving first-line chemotherapy

scientific article published on 08 August 2020

Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

scientific article published on 02 April 2019

Sharing study results with trial participants: time for action.

scientific article

Should a sentinel node biopsy be performed in patients with high-risk breast cancer?

scientific article published on 10 August 2011

Silicone controversy: a survey of women with breast cancer and silicone implants

scientific article published on 01 September 1993

Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases

scientific article

Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101.

scientific article

Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer

scientific article published on 24 March 2014

Standards for follow-up care of patents with breast cancer

scientific article

Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival

scientific article published on August 2016

Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer

scientific article published in February 2008

Surgical Options and Locoregional Recurrence in Patients Diagnosed with Invasive Lobular Carcinoma of the Breast

scientific article published on 18 April 2015

Surveillance Mammography in Older Patients With Breast Cancer-Can We Ever Stop?: A Review

scientific article

Surveillance testing among survivors of early-stage breast cancer

scientific article

Survival benefit needed to undergo chemotherapy: Patient and physician preferences.

scientific article published on 21 March 2017

Survival implications associated with variation in mastectomy rates for early-staged breast cancer

scientific article

Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer

scientific article published on 23 October 2020

Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline Update

scientific article published on 25 June 2018

Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline

scientific article published on 05 May 2014

TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer

scientific article

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.

scientific article

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases

scientific article published on 12 March 2019

TBCRC 030: A phase II study of preoperative cisplatin vs. paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker

scientific article published on 13 August 2020

TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial)

scientific article published on 25 February 2020

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

scientific article published on 29 October 2020

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer

scientific article

TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer

scientific article published 2019

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

scientific article published on 04 June 2018

Tailoring adjuvant chemotherapy regimens for patients with triple negative breast cancer

scientific article published on 05 August 2015

Tangential radiotherapy without axillary surgery in early-stage breast cancer: results of a prospective trial

scientific article published on 18 April 2008

Ten years of HER2-directed therapy: still questions after all these years

scientific article published on 8 May 2008

Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare data

scientific article

Testing for hereditary breast and ovarian cancer in the southeastern United States

scientific article published on 01 May 2000

Testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes: a decision analysis

scientific article published on October 1998

The American Society of Clinical Oncology's Blueprint for Transforming Clinical and Translational Cancer Research

scientific article published on 03 January 2012

The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy

scientific article published on 06 May 2019

The Legacy of Professor Aron Goldhirsch

scientific article published on 23 March 2020

The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer

scientific article published in 2022

The Role of Proliferation in Determining Response to Neoadjuvant Chemotherapy in Breast Cancer: A Gene Expression-Based Meta-Analysis.

scientific article published on 21 June 2016

The aromatase inhibitors as adjuvant therapy for hormone receptor-positive breast cancer

scientific article published on April 2003

The association of ambulatory care with breast cancer stage at diagnosis among Medicare beneficiaries

scientific article

The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care ⬇️

scientific article published on October 11, 2010

The combination of FLT3 and SYK kinase inhibitors is toxic to leukaemia cells with CBL mutations

scientific article published on 14 January 2020

The effect of age on delay in diagnosis and stage of breast cancer

scientific article

The ethical use of mandatory research biopsies ⬇️

scientific article published on August 2, 2011

The genomic landscape of intrinsic and acquired resistance to cyclin-dependent kinase 4/6 inhibitors in patients with hormone receptor positive metastatic breast cancer

scientific article published on 13 May 2020

The immune profile of small HER2-positive breast cancers: a secondary analysis from the APT trial

scientific article published on 01 April 2019

The impact of sharing results of a randomized breast cancer clinical trial with study participants

scientific article published on 10 June 2008

The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis

scientific article published on 01 June 2006

The role of socioeconomic status in adjustment after ductal carcinoma in situ

scientific article

The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer

scientific article

Time to diagnosis and breast cancer stage by race/ethnicity

scientific article

Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis.

scientific article

Timeliness in Breast Cancer Treatment-The Sooner, the Better

scientific article

Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer

scientific article

Topoisomerase II{alpha} amplification does not predict benefit from dose-intense cyclophosphamide, doxorubicin, and fluorouracil therapy in HER2-amplified early breast cancer: results of CALGB 8541/150013

scientific article published on 26 May 2009

Toxicity of Older and Younger Patients Treated With Adjuvant Chemotherapy for Node-Positive Breast Cancer: The Cancer and Leukemia Group B Experience

article

TransCONFIRM: Identification of a Genetic Signature of Response to Fulvestrant in Advanced Hormone Receptor-Positive Breast Cancer.

scientific article published on 16 May 2016

Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases

scientific article published on February 2016

Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm

scientific article published in August 2003

Trastuzumab emtansine: a novel antibody-drug conjugate for HER2-positive breast cancer

scientific article

Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831.

scientific article

Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study

scientific article published on 01 September 2007

Trastuzumab/chemotherapy combinations in metastatic breast cancer

scientific article

Treatment of early-stage human epidermal growth factor 2-positive cancers among medicare enrollees: age and race strongly associated with non-use of trastuzumab

scientific article published on 2 August 2016

Trends in racial and age disparities in definitive local therapy of early-stage breast cancer

scientific article published on 22 December 2008

Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers

scientific article

Triple-negative breast cancer: disease entity or title of convenience?

scientific article published on 28 September 2010

Triple-negative breast cancer: risk factors to potential targets

scientific article published on December 2008

Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

scientific article published on 11 December 2019

Tumor mutational burden and PTEN alterations as molecular correlates of response to PD-1/L1 blockade in metastatic triple-negative breast cancer

scientific article published on 04 February 2020

Tumor therapeutic response and vessel tortuosity: preliminary report in metastatic breast cancer

scientific article published on 01 January 2006

Tumor-infiltrating lymphocytes and response to platinum in triple-negative breast cancer.

scientific article published on 5 January 2015

Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret

scientific article published on 19 October 2005

Unraveling the clinicopathological features driving the emergence of mutations in metastatic breast cancer

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

scientific article published on 01 November 2019

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer.

scientific article

Use and duration of chemotherapy in patients with metastatic breast cancer according to tumor subtype and line of therapy

scientific article published in January 2014

Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study

scientific article published in June 2003

Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503)

scientific article

VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy

scientific article

Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States

scientific article published on 13 January 2018

Variation in the Attitudes of Medical Oncologists Toward Research Biopsies in Patients With Metastatic Breast Cancer

scientific article

Variation in the use of granulocyte-colony stimulating factor for dose dense paclitaxel: A single institution retrospective study

scientific article

Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional study

scientific article published on 10 March 2015

Weathering the Storm: Managing Older Adults with Breast Cancer Amid COVID-19 and Beyond

scientific article published on 25 May 2020

Web-based survey of fertility issues in young women with breast cancer.

scientific article

Why women gain weight with adjuvant chemotherapy for breast cancer

scientific article published on July 1993

Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809 ⬇️

scientific article published on February 14, 2011

p16<sup>INK4A</sup>-deficiency predicts response to combined HER2 and CDK4/6 inhibition in HER2+ breast cancer brain metastases

scientific article published on 18 March 2022

p53 Expression in node-positive breast cancer patients: results from the Cancer and Leukemia Group B 9344 Trial (159905).

scientific article

Paulina is supported by:

About Paulina

Help